Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02808832 · ClinicalTrials.gov registry record · NA
An HPV Vaccine Provider Intervention in Safety Net Clinics
A NA study, sponsored by Meharry Medical College.
- Completed
- Registry status
- NA
- Development phase
- 806
- Enrollment target
NCT02808832: Completed NA study, sponsored by Meharry Medical College.
NCT02808832 is a NA study that has completed, run by Meharry Medical College. The registered enrollment target is 806 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02808832, a NA study, has completed, sponsored by Meharry Medical College.
- COMPLETED
- Registry status
- NA
- Development phase
- 806 participants
- Enrollment target
Study Summary
The purpose of this study is to develop, deliver and evaluate a provider intervention for mothers and their children to encourage receipt of the human papillomavirus (HPV) vaccine in the children and appropriate cervical cancer screening in the mothers.
Primary Outcome
Although completion of the 3-dose HPV vaccine series is recommended within 6 months, the investigators measured completion within 12 months.
Interventions
- BEHAVIORAL Educational materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 806 participants |
| Start Date | 2010-09 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02808832 record still lists
NCT02808832 is an interventional study that assigns participants to a tested intervention. The registered 806 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 1 intervention - of which Educational materials is the first listed.
NCT02808832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02808832 about?
NCT02808832 is a clinical study titled "An HPV Vaccine Provider Intervention in Safety Net Clinics". The purpose of this study is to develop, deliver and evaluate a provider intervention for mothers and their children to encourage receipt of the human papillomavirus (HPV) vaccine in the children and appropriate cervical cancer screening in the mothers.
What is the current status of trial NCT02808832?
This trial is currently completed. It is a NA study. The enrollment target is 806 participants. The study started on 2010-09. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02808832?
The interventions under investigation include: Educational materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT02808832?
This trial is sponsored by Meharry Medical College, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02808832's enrollment target sits among peer trials
806 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia